Skip to content

Public FDA record

Z-1265-2020: i-STAT G3+ cartridge (blue), List No. 03P78-50, UDI (01) 00054749002283 - Product Usage: The i-STAT G3+ c

Recall record Z-1265-2020 for Abbott Point Of Care Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1265-2020
Company in FDA record
Abbott Point Of Care Inc.
FDA classification date
Feb 18, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Marketed without a 510(k). Abbott Point of Care has determined that it does not have sufficient clinical evidence to fully characterize the performance of the blue i-STAT G3+ cartridges and therefore will no longer distribute the i-STAT G3+ (blue) cartridge in the United States as of May 1, 2020.

Source facts

Action
On January 15, 2020, the recalling firm notified customers via letters, emails, follow-up phone calls/visits by sales representatives, and a website posting at www.pointofcare.abbott. Customers were instructed to take the following actions: " During the transition, clinicians and laboratory staff should be informed that the performance of the i-STAT G3+ (BLUE) cartridge has not been fully characterized by Abbott. " Clinicians should be advised to consider a patients signs, symptoms, history, and results of other diagnostic tests when interpreting results from these cartridges. If the results do not match the patients clinical presentation, the patient sample should be retested using an alternate test method or a reference laboratory. " Report any questions or concerns you have regarding the i-STAT G3+ cartridge performance to Abbott Point of Care Technical Support at 1-800-366-8020 option 1, or via email at techsvc@apoc.abbott.com. If you have forwarded any i-STAT G3+ (BLUE), 6+ (WHITE), E3+ (WHITE), and EC4+ (WHITE) cartridges to another facility, we request that you please provide a copy of this letter to them. ***Updated 4/7/2020*** On April 2, 2020, Abbott Point of Care sent an additional letter communicating the following: In response to the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS) are allowing the use of the i-STAT CG4+(blue) and i-STAT G3+ (blue) blood gas cartridges in laboratories and facilities that hold a Certificate of Compliance or Accreditation to run tests of moderate complexity. Specifically, during the COVID-19 pandemic Abbott Point of Care may continue to distribute the i-STAT CG4+ (blue) and i-STAT G3+ (blue) cartridges, and facilities that possess a non-waived CLIA certificate (i.e., facilities that hold a Certificate of Compliance or Accreditation) may use them with venous and arterial whole blood samples as tests of moderate comp
Initiated
2020-01-14
Root cause
No Marketing Application
Terminated
2021-04-12
Distribution
US Nationwide distribution.
Recall number
Z-1265-2020
Recall status
Terminated
CDRH record ID
179124
FDA classified
2020-02-18
Recall event number
84730

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗